HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Tranexamic acid: from trauma to routine perioperative use.

AbstractPURPOSE OF REVIEW:
Optimizing hemostasis with antifibrinolytics is becoming a common surgical practice. Large clinical studies have demonstrated efficacy and safety of tranexamic acid (TXA) in the trauma population to reduce blood loss and transfusions. Its use in patients without pre-existing coagulopathies is debated, as thromboembolic events are a concern. In this review, perioperative administration of TXA is examined in nontrauma surgical populations. Additionally, risk of thromboembolism, dosing regimens, and timing of dosing are assessed.
RECENT FINDINGS:
Perioperative use of TXA is associated with reduced blood loss and transfusions. Thromboembolic effects do not appear to be increased. However, optimal dosing and timing of TXA administration is still under investigation for nontrauma surgical populations.
SUMMARY:
As part of a perioperative blood management programme, TXA can be used to help reduce blood loss and mitigate exposure to blood transfusion.
AuthorsJeff Simmons, Robert A Sikorski, Jean-Francois Pittet
JournalCurrent opinion in anaesthesiology (Curr Opin Anaesthesiol) Vol. 28 Issue 2 Pg. 191-200 (Apr 2015) ISSN: 1473-6500 [Electronic] United States
PMID25635366 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • Antifibrinolytic Agents
  • Tranexamic Acid
Topics
  • Antifibrinolytic Agents (therapeutic use)
  • Blood Coagulation Disorders (drug therapy)
  • Hemostasis
  • Humans
  • Perioperative Care (methods)
  • Tranexamic Acid (therapeutic use)
  • Wounds and Injuries (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: